Nurix Therapeutics Inc (NASDAQ:NRIX) price closed lower on Monday, April 15, dropping -7.65% below its previous close.
A look at the daily price movement shows that the last close reads $16.74. Taking into account the 52-week price action we note that the stock hit a 52-week high of $18.12 and 52-week low of $4.22. The stock added 10.11% on its value in the past month.
Nurix Therapeutics Inc, which has a market valuation of $759.86 million. Analysts tracking NRIX have forecast the quarterly EPS to shrink by -0.76 per share this quarter, while the same analysts predict the annual EPS to hit -$3.12 for the year 2024 and up to -$3.27 for 2025. In this case, analysts estimate an annual EPS growth of -17.70% for the year and -4.80% for the next year.
On average, analysts have forecast the company’s revenue for the quarter will hit $20.77 million, with the likely lows of $12.7 million and highs of $32.5 million. Staying with the analyst view, there is a consensus estimate of $69.06 million for the company’s annual revenue in 2024. Per this projection, the revenue is forecast to grow -10.30% below that which the company brought in 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with 1 upward and — downward reviews. On the technical perspective front, indicators give NRIX a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that NRIX’s price is at present 7.75% off the SMA20 and 23.97% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 55.49, with weekly volatility standing at 12.98%. The indicator jumps to 9.59% when calculated based on the past 30 days. Nurix Therapeutics Inc (NASDAQ:NRIX)’s beta value is holding at 2.00, while the average true range (ATR) indicator is currently reading 1.42.
An analysis of the Nurix Therapeutics Inc (NASDAQ:NRIX) stock in terms of its daily trading volume indicates that the 3-month average is 904.79K.
Current records show that the company has 48.72M in outstanding shares. The insiders’ percentage holdings are 7.90% of outstanding shares while the percentage share held by institutions stands at 88.63%. But the 49.81% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
